UK markets close in 5 hours 8 minutes

Viemed Healthcare, Inc. (VMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.10-0.01 (-0.14%)
At close: 04:00PM EDT
7.10 0.00 (0.00%)
After hours: 04:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 275.63M
Enterprise value 277.85M
Trailing P/E 28.40
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.48
Price/book (mrq)2.37
Enterprise value/revenue 1.43
Enterprise value/EBITDA 7.21

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3-27.18%
S&P500 52-week change 328.04%
52-week high 310.44
52-week low 35.90
50-day moving average 38.36
200-day moving average 37.87

Share statistics

Avg vol (3-month) 3181.03k
Avg vol (10-day) 3205.1k
Shares outstanding 538.82M
Implied shares outstanding 638.82M
Float 833.96M
% held by insiders 112.51%
% held by institutions 166.25%
Shares short (30 Apr 2024) 4437.8k
Short ratio (30 Apr 2024) 44.17
Short % of float (30 Apr 2024) 41.29%
Short % of shares outstanding (30 Apr 2024) 41.13%
Shares short (prior month 28 Mar 2024) 4406.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 5.32%
Operating margin (ttm)4.78%

Management effectiveness

Return on assets (ttm)7.16%
Return on equity (ttm)9.55%

Income statement

Revenue (ttm)194.04M
Revenue per share (ttm)5.04
Quarterly revenue growth (yoy)27.90%
Gross profit (ttm)N/A
Net income avi to common (ttm)10.33M
Diluted EPS (ttm)0.25
Quarterly earnings growth (yoy)5.70%

Balance sheet

Total cash (mrq)7.31M
Total cash per share (mrq)0.19
Total debt (mrq)9.53M
Total debt/equity (mrq)8.20%
Current ratio (mrq)1.28
Book value per share (mrq)2.99

Cash flow statement

Operating cash flow (ttm)35.89M
Levered free cash flow (ttm)10.81M